Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
498.00    -16.00 (-3.11%)
Bid:
498.00
Ask:
506.00
Spread: 8.00 (1.606%)
Market Cap: £251.41m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

Corporate, Financing and Trading Update

24 Mar 2023 07:00

RNS Number : 0872U
Fisher (James) & Sons plc
24 March 2023
 

This announcement contains inside information

 

24 March 2023

 

James Fisher and Sons plc

 

Corporate, Financing and Trading Update

 

James Fisher and Sons plc (FSJ.L) ("James Fisher", the "Group" or the "Company"), the leading provider of marine services is today providing a corporate, financing and trading update, the highlights of which are as follows:

 

· Publication of FY 2022 financial results to be delayed from 28 March 2023 to 28 April 2023

 

· This additional time provides an opportunity for the Group to complete the previously announced discussions in relation to its existing debt facilities

 

· The Group is also required to resolve certain technical restrictions, relating to the JFN Disposal, which have been waived through to 28 April 2023

 

· Audit process ongoing for FY 2022 - as a result, underlying operating profit from continuing operations now expected to be broadly in line with FY 2021

 

· Trading in first two months of 2023 was in line with the Group's expectations and ahead of the same period in the prior year

 

Corporate and Financing Update

 

As previously announced, the Group commenced discussions with its lending banks earlier this year regarding its existing debt facilities, which have maturity dates ranging from October 2023 to September 2024.

 

On 6 March 2023, the Group announced the sale of James Fisher Nuclear Holdings Limited ("JFN") and related properties (the "JFN Disposal"). As per the 6 March 2023 announcement, under the terms of the JFN Disposal agreement, several legacy parent company guarantees supporting the obligations of JFN were retained by James Fisher (the "PCGs"). The retention of the PCGs required consent under the Group's debt facilities prior to the sale of JFN, which was not obtained at the time. Following discussions, all lenders under the debt facilities have agreed waivers in respect of the PCGs until 28 April 2023.

 

The Group is grateful for the lenders' constructive approach and has accelerated engagement with them to seek a permanent solution in relation to the PCGs and to address its debt facilities by end of April 2023. 

 

The Group intends to publish its financial results for FY 2022 on 28 April 2023.

 

FY 2022 results

 

The audit process for FY 2022 is well-advanced, but ongoing, and remains subject to finalisation. At this stage, for the year ended 31 December 2022, the Group is expecting to report revenue from continuing operations of c.£475m (2021: £442.4m). Underlying operating profit from continuing operations is expected to be broadly in line with FY 2021.

 

James Fisher made good strategic progress over the second half of 2022 and in early 2023, divesting non-core businesses, as well as selling a significant fixed asset. The three business sales completed in December 2022 generated gross proceeds of c.£18.4m and net bank borrowings at 31 December 2022 were c.£135m. The sale of the Swordfish Dive Support Vessel, which was announced in December 2022, completed in January 2023, with cash proceeds of c.£20m now received.

 

Important changes have been made at the senior management level across several of our businesses. This will improve financial and performance accountability, as well as promote energetic and disciplined leaders from inside the organisation who have a demonstrable track record in achieving operational targets. Additionally, in order to simplify the Group further, from 1 January 2023 the Company has been reorganised into three new divisions which reflect our customer verticals, namely Energy, Defence and Maritime Transport.

 

Current trading update

 

The Group has made an encouraging start to 2023, with performance across January and February (the "Period") demonstrating continued progress, in line with the Board's expectations.

 

Group revenue in the Period saw strong year-on-year growth, with divisional trends similar to those seen towards the end of 2022. On both a continuing operations and total Group basis (including discontinued operations), James Fisher generated a small underlying operating profit in the Period, compared with a loss in the prior year.

 

The Group's net debt position is in line with management's expectations, benefiting from the receipt of Swordfish proceeds, and the Board expects the Group to continue to de-lever.

 

Whilst the economic climate more generally remains challenging, the Group has made clear strategic and financial progress over the last few months. With the benefit of a more focused portfolio and reinvigorated strategy, the Board is confident that the Group can carry forward this momentum through 2023, driving further financial and operational improvement.

 

 

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

01229 615400

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

The person responsible for making this announcement on behalf of the Company is Jean-François Bauer, Group General Counsel

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSELEDDEDSEFD
Date   Source Headline
22nd May 202612:22 pmRNS-RNotice of Defence Division Investor Event
18th May 20269:30 amRNSDirector/PDMR Shareholding
13th May 20261:48 pmRNSResult of AGM
22nd Apr 202611:15 amRNSDirector/PDMR Shareholding
8th Apr 20269:28 amRNSAnnual Report and Accounts and Notice of AGM
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
16th Feb 20267:00 amRNSNotice of Analyst and Investor Presentations
13th Feb 20263:10 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
27th Jan 20262:05 pmRNSHolding(s) in Company
15th Jan 20262:00 pmRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20254:08 pmRNSHolding(s) in Company
26th Sep 20258:35 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSHalf Year Results
21st Aug 20257:00 amRNSNotice of Analyst and Investor Presentations
1st Aug 20258:00 amRNSTotal Voting Rights and Share Capital
29th Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
16th Jul 20257:00 amRNSTotal Voting Rights and Share Capital
16th Jun 20254:35 pmRNSBlock listing six monthly return
23rd May 202511:46 amRNSBlock Listing Application
13th May 20252:36 pmRNSResults of Annual General Meeting
6th May 202510:39 amRNSNotification of Directors' Interest in Shares
28th Apr 20252:33 pmRNSNotification of Directors' Interest in Shares
4th Apr 20259:30 amRNSAnnual Report and Accounts 2024 and Notice of AGM
20th Mar 20257:00 amRNSFull Year Results
14th Mar 20259:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20257:56 amRNSHolding(s) in Company
16th Jan 20259:58 amRNSHolding(s) in Company
16th Dec 202410:59 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Sep 20243:35 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSSigning of £95m of committed bank facilities
10th Sep 20247:00 amRNSHalf year results
6th Sep 20242:10 pmRNSCompletion of Disposal of Martek Holdings Limited
8th Jul 20244:19 pmRNSHolding(s) in Company
8th Jul 202410:04 amRNSCompletion of RMSpumptools Disposal
28th Jun 20249:26 amRNSDirector Declaration
17th Jun 202411:32 amRNSBlock listing six monthly return
13th Jun 20246:15 pmRNSResults of the General Meeting
12th Jun 20241:43 pmRNSNotification of Directors' Interests in Shares
30th May 20244:48 pmRNSResults of Annual General Meeting
30th May 20243:34 pmRNSDirector Declaration
24th May 20243:18 pmRNSPublication of Circular and Notice of GM
29th Apr 20245:39 pmRNSAnnual Report and Accounts 2023 and Notice of AGM
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.